Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada
- 20 May 2003
- Vol. 21 (25-26), 3757-3764
- https://doi.org/10.1016/s0264-410x(03)00361-x
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Spread ofStreptococcus pneumoniaeand Antibiotic‐ResistantS. pneumoniaefrom Day‐Care Center Attendees to Their Younger SiblingsThe Journal of Infectious Diseases, 2002
- Reduction of Nasopharyngeal Carriage ofStreptococcus pneumoniaeafter Administration of a 9‐Valent Pneumococcal Conjugate Vaccine to Toddlers Attending Day Care CentersThe Journal of Infectious Diseases, 2002
- Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis MediaNew England Journal of Medicine, 2001
- Surveillance of Invasive Streptococcus pneumoniae Infection in the Province of Quebec, Canada, from 1996 to 1998: Serotype Distribution, Antimicrobial Susceptibility, and Clinical CharacteristicsJournal of Clinical Microbiology, 2001
- Invasive Pneumococcal Infections in Canadian Children, 1991-1998: Implications for New Vaccination StrategiesClinical Infectious Diseases, 2000
- Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in childrenThe Pediatric Infectious Disease Journal, 2000
- A benefit-cost analysis of two-dose measles immunization in CanadaVaccine, 1998
- Reduction of Nasopharyngeal Carriage of Pneumococci during the Second Year of Life by a Heptavalent Conjugate Pneumococcal VaccineThe Journal of Infectious Diseases, 1996
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Pneumonia in pediatric outpatients: Cause and clinical manifestationsThe Journal of Pediatrics, 1987